A Changing Treatment Paradigm of Myasthenia Gravis: A Focus on Novel Targeted Treatments

This presentation will educate healthcare providers on the historical treatment of myasthenia gravis, how the newer agents change the treatment paradigm, and demonstrate how to treat various subtypes of myasthenia gravis through patient case examples.
Jonathan Katz, MD
Gil Wolfe, MD, FAAN
Format: Microsoft PowerPoint (.ppt)
File Size: 464 KB
Released: September 23, 2022

Acknowledgements

Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

 
Independent Educational Activity

Related Content

Dr Christoph U. Correll: Bold Panoramic Grasp of Tardive Dyskinesia at the Inaugural Psychiatry Summit 2022, from Clinical Care Options (CCO)

Christoph U. Correll, MD Physicians: maximum of 1.0 AMA PRA Category 1 Credit Registered Nurses: 1.0 Nursing contact hour Pharmacists: 1.0 contact hour (0.1 CEUs) Physician Assistants: maximum of 1.0 hour of AAPA Category 1 CME credit Psychologists: 1.0 APA CE Credit Social Workers: 1.0 ACE CE Credit Released: April 19, 2022 Expired: April 18, 2023

Slides from a presentation that educates clinicians on tardive dyskinesia.

Christoph U. Correll, MD Released: March 23, 2022

Slides from a presentation that educates clinicians on myth busting in psychopharmacology

Leslie Citrome, MD, MPH Released: March 22, 2022

Dr Jonathan Meyer presents on pharmacotherapy of antipsychotic-induced movement disorders, from Clinical Care Options (CCO)

Jonathan M. Meyer, MD Physicians: maximum of 1.0 AMA PRA Category 1 Credit Registered Nurses: 1.0 Nursing contact hour Pharmacists: 1.0 contact hour (0.1 CEUs) Physician Assistants: maximum of 1.0 hour of AAPA Category I CME credit Social Workers: 1.0 ACE CE Credit Psychologists: 1.0 APA CE Credit Released: February 16, 2022 Expired: February 15, 2023

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings